Lois Donovan MD FRCPC is a Clinical Professor at the University of Calgary AB Canada in the Cumming School of Medicine, in the Department of Medicine, Division of Endocrinology and Metabolism, and Department of Obstetrics and Gynecology.
She is a clinician researcher with a clinical and research focus on Diabetes in Pregnancy and Automated Insulin Delivery. Her work includes:
- She was the Co-PI of the CIRCUIT trial, an international multicentre trial, published in JAMA.
- She was a co-author for the international consensus statement, Application of continuous glucose monitoring and automated insulin delivery technologies for pregnant women with type 1, type 2, or gestational diabetes.
- She is a coauthor of the Diabetes Canada Diabetes in Pregnancy Clinical Practice Guidelines and is actively working on a team updating the Canadian Diabetes in Pregnancy guidelines. She was recognized nationally in 2019 when she received the Diabetes Canada award for contributions to the field of diabetes in pregnancy in Canada.
- She was the Co-PI of the CLIMB trial: A Randomized Trial of Closed-Loop Insulin Delivery Postpartum Type 1 Diabetes (Donovan et al 2023 Diabetes Care), Glycaemic patterns during breastfeeding with postpartum use of closed-loop insulin delivery in women with type 1 diabetes (Donovan et al Diabetologia. 2024 67(10):2154-2159), and Influence of Maternal Glycemia on Breast Milk Composition and Volume Ingested by Infants of Mothers with Type 1 Diabetes (Donovan et al Diabetes Care. 2025 1;48(8):1337-1341).
- She was a co-investigator and site PI for CONCEPTT, a multicentre international RCT: Continuous glucose monitoring in pregnant women with type 1 diabetes (Feig, DS, Donovan LE et al Lancet 2017).